License the latest technology from Imperial College London
Technology available for licensing
Imperial College London is among the world’s leading research universities, and one of the few focused exclusively on Science, Technology, Engineering, Medicine and Business. Technology developed by Imperial’s world-leading researchers is protected and packaged by our expert commercialisation specialists.
Available technologies span all areas of research undertaken at Imperial. If your business is considering licensing technology, you can view available technologies and enquire directly through this site.
Browse technologies and innovations derived from research undertaken by academics at Imperial College London
A novel gene therapy for Huntington’s Disease that leverage zinc finger protein technology.
A new method to change the state of individual magnetic nanoparticles within a dense array using a low cost, low-power laser for data storage technology and potential application in neuromorphic ‘in-memory’ computing.
The invention A suite of novel zinc carbonic anhydrase (CA) mimics have been developed, based upon the structure of the previously published mimic ZnL1S. By changing the atoms within the ligand structure i.e. from nitrogens to sulfurs, and with various arrangements of the same or different ligands around the central metal, and thereby mimicking more […]
The invention A functional catalytic material that selectively oxidises organic molecules utilising molecular oxygen from the air is presented. The materials allow for heterogeneous reactions of molecules of interest within a liquid or in the gas phase with high yield and selectivity under mild conditions. Selective oxidation catalyst: Oxidation of bulk chemicals on a large […]
A novel nacre-like fibre coating and application method that can improve the mechanical qualities of high performance composites, enabling lightweight nanocomposites with high strength, stiffness and toughness.
A technique to enhance light extraction efficiency in light emitting diodes
A novel, high efficiency low pressure ratio turbine developed by engineers at Imperial College London to capture a significant portion of residual exhaust energy with negligible effect on engine base performance.
Novel chemical additives that reduce the fluid film friction of lubricated mechanical components under elastohydrodynamic conditions
Red blood cell-derived vesicles (RBCVs) for use in targeted delivery of thrombolytic drugs to blood clots.
Small molecule inhibitors with potential for use in the treatment of neurodegenerative diseases such as Huntington's disease, viral conditions such as HIV, and cancers
Licensing and IP performance 2019/20
Imperial inventors submitted 250 invention disclosures to our IPC team during the year
Imperial College London's licensing portfolio comprises 244 licences
Imperial filed 137 patents (including PCT applications) during the year
Imperial's patent portfolio reached 331 patents during the year
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.